ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in ImageneBio, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 57
- −12 vs. Q2 2024
- Shares held
- 28.4M
- −246.0K (−0.9%) vs. Q2 2024
- Total value
- $49.1M
- +$1.86M (+3.9%) vs. Q2 2024
- New holders
- 6
- 12 more added
- Sold out
- 18
- 19 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $36.8M |
| Q1 2026 | 39 | $26.8M |
| Q4 2025 | 41 | $32.9M |
| Q3 2025 | 33 | $38.3M |
| Q2 2025 | 41 | $42.6M |
| Q1 2025 | 46 | $41.9M |
| Q4 2024 | 53 | $52.0M |
| Q3 2024 | 57 | $49.1M |
| Q2 2024 | 70 | $47.9M |
| Q1 2024 | 57 | $42.7M |
| Q4 2023 | 54 | $63.8M |
| Q3 2023 | 58 | $141.6M |
| Q2 2023 | 52 | $204.7M |
| Q1 2023 | 39 | $86.2M |
| Q4 2022 | 34 | $69.9M |
| Q3 2022 | 42 | $93.2M |
| Q2 2022 | 46 | $118.7M |
| Q1 2022 | 48 | $167.8M |
| Q4 2021 | 49 | $343.6M |
| Q3 2021 | 39 | $271.8M |
| Q2 2021 | 42 | $293.2M |
| Q1 2021 | 27 | $538.5M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding ImageneBio, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 72 | $125 | 0.00% | −41,746−99.8% | Reduced |
| Nisa Investment Advisors, LLC | 99 | $171 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 108 | $187 | 0.00% | −62−36.5% | Reduced |
| Bank of America Corp | 199 | $344 | 0.00% | −128−39.1% | Reduced |
| SRS Capital Advisors, Inc. | 299 | $518 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 849 | $1.47K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,503 | $2.60K | 0.00% | +1,503 | New |
| Tower Research Capital LLC (TRC) | 1,875 | $3.24K | 0.00% | −18,257−90.7% | Reduced |
| Russell Investments Group, Ltd. | 2,728 | $4.72K | 0.00% | +412+17.8% | Added |
| Catalyst Funds Management Pty Ltd | 4,500 | $7.79K | 0.00% | 00.0% | Unchanged |
| Point72 (DIFC) Ltd | 6,716 | $11.6K | 0.00% | +2,324+52.9% | Added |
| LPL Financial LLC | 12,000 | $20.8K | 0.00% | +12,000 | New |
| Charles Schwab Investment Management Inc | 12,066 | $20.9K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 15,403 | $26.6K | 0.00% | −25,471−62.3% | Reduced |
| Qube Research & Technologies Ltd | 17,352 | $30.0K | 0.00% | −17,589−50.3% | Reduced |
| JustInvest LLC | 17,795 | $30.8K | 0.00% | −515−2.8% | Reduced |
| Berkshire Asset Management LLC | 20,000 | $33.0K | 0.00% | 00.0% | Unchanged |
| Point72 Asia (Singapore) Pte. Ltd. | 22,146 | $38.3K | 0.01% | −23,374−51.3% | Reduced |
| Corsair Capital Management, L.P. | 24,830 | $43.0K | 0.01% | 00.0% | Unchanged |
| Prudential Financial Inc | 29,800 | $51.6K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 37,270 | $64.5K | 0.00% | −18,570−33.3% | Reduced |
| FMR LLC | 38,374 | $66.4K | 0.00% | +18,607+94.1% | Added |
| Dimensional Fund Advisors LP | 38,621 | $66.8K | 0.00% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 44,635 | $77.2K | 0.01% | −2,050−4.4% | Reduced |
| Northern Trust Corp | 48,109 | $83.2K | 0.00% | −168,742−77.8% | Reduced |
| Prelude Capital Management, LLC | 50,638 | $87.6K | 0.01% | +50,638 | New |
| Susquehanna International Group, LLP | 57,090 | $98.8K | 0.00% | −26,128−31.4% | Reduced |
| Goldman Sachs Group Inc | 58,623 | $101.4K | 0.00% | −215,211−78.6% | Reduced |
| JBF Capital, Inc. | 72,647 | $125.7K | 0.02% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 72,890 | $126.1K | 0.02% | 00.0% | Unchanged |
| State Street Corp | 80,353 | $139.0K | 0.00% | 00.0% | Unchanged |
| Deuterium Capital Management, LLC | 80,579 | $139.4K | 0.26% | +10.0% | Added |
| Vazirani Asset Management LLC | 115,668 | $200.1K | 0.36% | +115,668 | New |
| BBR Partners, LLC | 130,000 | $224.9K | 0.02% | +110,000+550.0% | Added |
| Two Sigma Investments, LP | 156,713 | $271.1K | 0.00% | −80,165−33.8% | Reduced |
| Bridgeway Capital Management, LLC | 158,400 | $274.0K | 0.01% | +76,100+92.5% | Added |
| Citadel Advisors LLC | 165,015 | $285.5K | 0.00% | −79,675−32.6% | Reduced |
| Barclays PLC | 195,311 | $337.9K | 0.00% | −733−0.4% | Reduced |
| Two Sigma Advisers, LP | 202,100 | $349.6K | 0.00% | +28,900+16.7% | Added |
| FNY Investment Advisers, LLC | 231,383 | $400.0K | 0.19% | +231,383 | New |
| Millennium Management LLC | 249,417 | $431.5K | 0.00% | −105,293−29.7% | Reduced |
| Geode Capital Management, LLC | 271,026 | $469.0K | 0.00% | +14,319+5.6% | Added |
| Acadian Asset Management LLC | 325,713 | $562.0K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 352,176 | $609.3K | 0.00% | +352,176 | New |
| Sofinnova Investments, Inc. | 382,616 | $661.9K | 0.05% | 00.0% | Unchanged |
| Jacobs Levy Equity Management, Inc | 388,748 | $672.5K | 0.00% | −35,629−8.4% | Reduced |
| Renaissance Technologies LLC | 400,600 | $693.0K | 0.00% | −75,800−15.9% | Reduced |
| Acuitas Investments, LLC | 449,656 | $777.9K | 0.35% | +49,777+12.4% | Added |
| NEA Management Company, LLC | 600,063 | $1.04M | 0.06% | +30,013+5.3% | Added |
| BML Capital Management, LLC | 723,288 | $1.25M | 0.74% | +138,174+23.6% | Added |
| Adage Capital Partners GP, L.L.C. | 987,900 | $1.71M | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,384,664 | $2.40M | 0.00% | +20,194+1.5% | Added |
| Omega Fund Management, LLC | 2,249,123 | $3.89M | 2.43% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 3,539,358 | $6.12M | 0.11% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 4,091,118 | $7.08M | 1.37% | 00.0% | Unchanged |
| BVF Inc | 4,769,164 | $8.25M | 0.24% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $8.68M | 0.80% | 00.0% | Unchanged |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −135,297−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −73,431−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −64,641−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −60,628−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −44,933−100.0% | Sold out |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −30,240−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −28,053−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −27,666−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −26,893−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −21,861−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −16,607−100.0% | Sold out |
| Mirae Asset Global ETFs Holdings Ltd. | 0 | $0 | 0.00% | −16,270−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −5,005−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −4,842−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −3,856−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −1,585−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −985−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −283−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |